siRNA delivery system based on magnetic nanovectors: Characterization and stability evaluation

Area of Science:

• Biotechnology
• Nanomedicine
• Cancer Therapy

Background:

• Gene therapy using small interfering RNA (siRNA) shows promise for cancer treatment.
• Clinical application of siRNA is limited by the lack of effective delivery systems.
• Previous work optimized magnetic siRNA nanovectors (MSN) using superparamagnetic iron oxide nanoparticles (SPION) and chitosan.

Purpose of the Study:

• To further optimize and develop magnetic siRNA nanovectors (MSN) through rational design.
• To purify and characterize the optimized MSN for enhanced siRNA delivery.
• To evaluate the physical and chemical properties of the purified MSN (pMSN).

Main Methods:

• Purification of formulated MSN.
• Characterization of physical and chemical properties using capillary electrophoresis.
• Assessment of siRNA encapsulation efficiency, colloidal stability, and nuclease protection.

Main Results:

• Purified MSN (pMSN) achieved 95% siRNA encapsulation efficiency.
• pMSN demonstrated colloidal stability at pH 7.4.
• pMSN effectively protected siRNA from degradation for up to 24 hours with minimal release (<10%) at pH 7.4.

Conclusions:

• The optimized and purified magnetic siRNA nanovectors (pMSN) exhibit favorable characteristics for siRNA delivery.
• pMSN demonstrate potential for effective cancer theranostics.
• Further in vitro and in vivo evaluation of pMSN is warranted.